Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs ; volume:20 ; number:1 ; day:26 ; month:8 ; year:2020 ; pages:1-12 ; date:12.2020
BMC health services research ; 20, Heft 1 (26.8.2020), 1-12, 12.2020
- Urheber
-
Mata-Cases, M.
Mahon, J.
Mauricio, D.
Franch-Nadal, J.
Real, J.
Hex, N.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-020-05360-w
- URN
-
urn:nbn:de:101:1-2020101419510045306181
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mata-Cases, M.
- Mahon, J.
- Mauricio, D.
- Franch-Nadal, J.
- Real, J.
- Hex, N.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
Effect of glycaemic control on complications following cardiac surgery: literature review
Superficial Femoral Artery Calcification Is a Novel Risk Factor of Microvascular Complications in T2DM Patients
Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications
Reducing the impact of insulin sensitivity variability on glycaemic outcomes using separate stochastic models within the STAR glycaemic protocol
Liraglutide and Glycaemic Outcomes in the LEADER Trial
Quantifying the effect of complications on patient flow, costs and surgical throughputs
The pathophysiology of glucose intolerance in newly diagnosed, untreated T2DM
Costs of diabetes and its complications in Poland
Glycaemic Control in Diabetes
The combined effect of the T2DM susceptibility genes is an important risk factor for T2DM in non-obese Japanese: a population based case-control study
C(− 106)T polymorphism in ALR2 and risk of microvascular complications in T2DM patients in north Indian population
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
Effect of glycaemic control on complications following cardiac surgery: literature review
Superficial Femoral Artery Calcification Is a Novel Risk Factor of Microvascular Complications in T2DM Patients
Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications
Reducing the impact of insulin sensitivity variability on glycaemic outcomes using separate stochastic models within the STAR glycaemic protocol
Liraglutide and Glycaemic Outcomes in the LEADER Trial
Quantifying the effect of complications on patient flow, costs and surgical throughputs
The pathophysiology of glucose intolerance in newly diagnosed, untreated T2DM
Costs of diabetes and its complications in Poland
Glycaemic Control in Diabetes
The combined effect of the T2DM susceptibility genes is an important risk factor for T2DM in non-obese Japanese: a population based case-control study
C(− 106)T polymorphism in ALR2 and risk of microvascular complications in T2DM patients in north Indian population
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
Effect of glycaemic control on complications following cardiac surgery: literature review
Superficial Femoral Artery Calcification Is a Novel Risk Factor of Microvascular Complications in T2DM Patients
Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications
Reducing the impact of insulin sensitivity variability on glycaemic outcomes using separate stochastic models within the STAR glycaemic protocol
Liraglutide and Glycaemic Outcomes in the LEADER Trial
Quantifying the effect of complications on patient flow, costs and surgical throughputs
The pathophysiology of glucose intolerance in newly diagnosed, untreated T2DM
Costs of diabetes and its complications in Poland
Glycaemic Control in Diabetes
The combined effect of the T2DM susceptibility genes is an important risk factor for T2DM in non-obese Japanese: a population based case-control study